about
Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasisPrimary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategiesEnhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancerThe microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively.Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.Mouse models of colorectal cancer.Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients.Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.Using genetics and genomics strategies to personalize therapy for cancer: focus on melanomaAngiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.The Met oncogene and basal-like breast cancer: another culprit to watch out for?Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.Effects of the proapoptotic regulator Bcl-2/adenovirus EIB 19-kDa-interacting protein 3 on the chemosensitivity of human colon cancer cell lines.Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon SystemAutonomous inhibition of apoptosis correlates with responsiveness of colon carcinoma cell lines to ciglitazone.Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils.Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubesAn EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells.Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs.Silencing of Wnt5a during colon cancer metastasis involves histone modifications.Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.NMT1 (N-myristoyltransferase 1).Exploring Different Strategies for Efficient Delivery of Colorectal Cancer TherapyPP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer.Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic responseCompound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 InteractionsCo-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cellsGenistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells.Risk factors and therapeutic targets in pancreatic cancer.Molecular targeted therapies in head and neck cancer--an update of recent developments-Recently identified and potential targets for colon cancer treatment.Colon cancer stem cells: implications in carcinogenesis.Modulating autophagy: a strategy for cancer therapyNovel targeted therapies in head and neck cancer.Targeted therapy in head and neck cancer.Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.
P2860
Q27002388-AC2AE228-67A3-45B5-A073-60FC917D14DDQ27015224-20C6C710-1A6A-46AF-BE56-3B758FE6B39DQ28484922-6F1FC233-5C2D-4D0A-B1D7-7D80C368DF6EQ30511980-293D2C44-69C4-4287-86BF-BA7193724B05Q30538531-1BE0443B-73BD-455B-99F6-07A496998D5FQ33579734-4582F3E3-3E49-4AFB-9743-BD6FE3E22A96Q33620070-2CDBA639-D90B-45C6-9063-4AFD696E92C2Q33838524-8E3456CC-01B3-419B-8678-80077BA89DF6Q33965328-EA4467CD-9ADA-4BC4-88FC-55F040127861Q34101582-6EABEEDA-1EE6-45EB-89C6-C4140B96E3F5Q34173500-468EE323-B0CA-43F1-B4F9-AB59AA7008FCQ34188530-DD336F02-8984-41D6-A40F-677FE5CE836EQ34498134-387252CE-9AA1-437E-BEDC-E5832369A79AQ34608072-EC9E8041-B3BE-4E84-9209-53DFAB34963BQ34680692-09EE2AC3-8EC8-40F6-A973-4638D3E533A9Q34956634-2AFFE6B9-798C-49B7-BE1D-3A828596D40EQ35069643-600EE386-FA32-4AE7-8184-ED7080BCF538Q35190834-3FAE5729-DBA5-481F-A2A0-5C864141FBE4Q35234708-0CDE56F7-319F-4AE9-B5F5-BC9C942F35F7Q35623065-474CE67B-7EDA-4E5B-BCF8-E56616DFF92EQ35832549-B40EEFBD-41BE-4C69-BA08-1EB7676D9BD4Q36025321-B3B1B450-428D-4AA6-A332-A51DC068170FQ36100968-B8747B59-7556-47D6-88BA-C522038B9444Q36176102-78C97BE7-63D4-4041-B87C-B30074F7153EQ36227163-94DCE17A-E040-41AD-9B3A-BA13CF8D2343Q36324618-3BE8FEAE-D02A-46BF-9843-F51275CBB7D1Q36437685-AA5E6038-0D3B-4C50-A26F-66439DCAF3B6Q36524239-AB86A693-8036-460D-89F6-4AB12D1FE3CDQ36656035-2A59FCDC-E2CD-4B1F-A8DD-63E11694E8B0Q36883777-D60FBBD5-7C17-49D2-9FDF-846CF10B9DDCQ37091712-265F9B6D-D6AD-4D92-9F38-C067CCC17272Q37317310-E423CD84-A019-47CA-ADC3-FFFAA7A8A67AQ37732457-C8E4F88C-C2A9-40EE-825C-BAEDFC15E700Q37763104-20C8073E-33D6-4900-A444-555498FF4A9DQ37825224-934D02EB-D09D-42E2-9F7A-8CFA800BA64EQ37940741-8A59522D-6DEA-413A-99CE-AC5EEB6B9AE7Q37975224-FB66E5B8-F4F1-4C5E-BF4B-AFDABC4AB2CFQ37988981-C0C6CCC4-C8E9-4BA3-8ECE-CFDF655FA8DFQ38017299-6E21A582-BCBE-4A5B-A2C6-165661EC966AQ38042938-51A90766-B676-4041-954E-C03E558FC136
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evolving treatment of advanced colon cancer.
@en
Evolving treatment of advanced colon cancer.
@nl
type
label
Evolving treatment of advanced colon cancer.
@en
Evolving treatment of advanced colon cancer.
@nl
prefLabel
Evolving treatment of advanced colon cancer.
@en
Evolving treatment of advanced colon cancer.
@nl
P1476
Evolving treatment of advanced colon cancer
@en
P2093
Neil H Segal
P304
P356
10.1146/ANNUREV.MED.60.041807.132435
P577
2009-01-01T00:00:00Z